Advanced company searchLink opens in new window

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

Company number 03107561

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
23 Jan 2024 MR01 Registration of charge 031075610003, created on 19 January 2024
17 Jan 2024 PSC05 Change of details for Gw Pharmaceuticals Ltd as a person with significant control on 6 April 2016
12 Jan 2024 CS01 Confirmation statement made on 2 January 2024 with no updates
08 Jan 2024 AA Full accounts made up to 31 December 2022
21 Nov 2023 AD01 Registered office address changed from Sovereign House Vision Park, Chivers Way Histon Cambridge CB24 9BZ to Building 730 Kent Science Park Sittingbourne Kent ME9 8AG on 21 November 2023
20 Nov 2023 CERTNM Company name changed gw research LIMITED\certificate issued on 20/11/23
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2023-11-20
26 Jun 2023 CH01 Director's details changed for Mr Luca Giacomo Marchetti on 22 June 2023
11 May 2023 AP01 Appointment of Mr Luca Giacomo Marchetti as a director on 28 April 2023
14 Mar 2023 TM01 Termination of appointment of Iain Stuart Ward as a director on 13 January 2023
16 Jan 2023 AP01 Appointment of Mr David Spackman as a director on 13 January 2023
16 Jan 2023 AP01 Appointment of Ms Samantha Jane Laura Pearce as a director on 13 January 2023
13 Jan 2023 AP03 Appointment of Ms Aislinn Jane Doody as a secretary on 13 January 2023
13 Jan 2023 TM01 Termination of appointment of Adrian Campbell as a director on 1 January 2023
13 Jan 2023 TM02 Termination of appointment of Iain Stuart Ward as a secretary on 13 January 2023
04 Jan 2023 CS01 Confirmation statement made on 2 January 2023 with updates
16 Dec 2022 SH19 Statement of capital on 16 December 2022
  • GBP 1
16 Dec 2022 CAP-SS Solvency Statement dated 12/12/22
16 Dec 2022 SH20 Statement by Directors
16 Dec 2022 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel share premium account 12/12/2022
  • RES06 ‐ Resolution of reduction in issued share capital
11 Nov 2022 AA Full accounts made up to 31 December 2021
01 Nov 2022 TM01 Termination of appointment of Christopher John Tovey as a director on 27 October 2022
25 Jan 2022 CS01 Confirmation statement made on 2 January 2022 with updates
25 Jan 2022 PSC05 Change of details for Gw Pharmaceuticals Plc as a person with significant control on 4 June 2021
10 Aug 2021 MA Memorandum and Articles of Association
06 Aug 2021 MA Memorandum and Articles of Association